Halder Venture Board Approves Warrant Issue, Capital Hike, Names New Auditor

Halder Venture Limited is set to increase its authorized share capital by ₹50 crore to ₹184.25 crore and has proposed issuing convertible warrants valued at ₹25 crore.

What happened today

Halder Venture Limited's Board of Directors accepted the resignation of its internal auditor, M/s Somnath Ray & Associates, on March 26, 2026. The board appointed M/s J Kumar Jain & Associates as the new internal auditor for the financial year 2025-26.

In a move to support future growth, the company resolved to increase its authorized share capital by ₹50 crore, from ₹134.25 crore to ₹184.25 crore.

The board also approved the issuance of 7,93,650 convertible warrants to P.K. Bio Link Private Limited at ₹315 per warrant, a preferential issue valued at approximately ₹25 crore.

Why this matters

Appointing a new internal auditor ensures ongoing financial oversight and compliance.

The proposed increase in authorized share capital offers greater financial flexibility for potential expansion, strategic investments, or debt management.

Issuing convertible warrants to P.K. Bio Link Private Limited signifies a potential capital infusion and strategic partnership, which could strengthen the company's balance sheet and support its business objectives.

The backstory

Halder Venture Limited, which operates in rice and edible oil manufacturing, recently completed a merger in December 2024 integrating five subsidiaries to create a more robust entity.

The company also approved acquiring a 52% stake in InQube Technologies Private Limited for ₹30.16 crore in February 2026, signaling expansion into agri-technology and carbon credits.

Earlier, M/s Somnath Ray & Associates had been appointed internal auditor following the death of Gautam K Dutta.

The company also faced a ₹5,42,800 fine from the BSE for non-compliance with Regulation 17(1) regarding board composition for the September 2025 quarter, after its waiver application was rejected.

What changes now

• New internal auditor appointed for FY 2025-26, enhancing financial governance.
• Increased authorized share capital provides strategic flexibility for future funding.
• Potential equity infusion and partnership via warrant issuance to P.K. Bio Link.
• Company is positioned for growth initiatives, supported by capital increase and warrant issue.

Risks to watch

Shareholder approval via postal ballot is critical; failure to secure it could halt the capital increase and warrant issuance.

The company must also manage its compliance history, including the recent BSE fine for board composition rules.

Peer comparison

Halder Venture operates in diverse sectors. Competitors like ITC Ltd, a diversified conglomerate with FMCG and agri-business interests, and agri-focused Avanti Feeds Ltd, known for specialized inputs, highlight varied business models. Halder Venture's capital structure and funding strategies will be crucial for its competitiveness.

What to track next

• Outcome of the postal ballot and shareholder vote on the proposed capital increase and warrant issuance.
• Performance and use of funds post-warrant issuance and capital infusion.
• Effectiveness of the new internal auditor in strengthening financial controls and compliance.
• Management's strategy for deploying the raised capital.